A springboard for growth
Among those that have benefited from the shortening of the negative list is Anchor Center for R&D and Certification (Shanghai). In 2014, the restriction on foreign-invested certification companies for imports and exports was removed, and this allowed the company to complete its registration in the Jinqiao area of Pudong in less than two weeks, said the company's executive president Si Rong.
Foreign companies have applauded the Shanghai FTZ's commitment to openness, which is one of the main factors why 14,285 foreign-invested projects with a combined registered capital of about $186.3 billion have been introduced to the Shanghai FTZ over the past decade.
Xia Mingchen, co-head of Asia Investment for Hamilton Lane, said that the establishment of the company's Shanghai office in the Shanghai FTZ in mid-February was aimed at growing the company footprint in China by making full use of the institutional innovation advantages of the Shanghai FTZ.
The institutional innovations made in the Shanghai FTZ have also been critical to driving technological innovation, especially in the pharmaceutical industry.
One such innovation is the Marketing Authorization Holders system for drugs.
